Marta Andres-Terre

Biopharma Analyst

2024 - Current

Biotechnology Research Analyst

2021 - 2024

Long/short biotechnology investing. Coverage of therapeutics including small and mid cap biotech, specialty pharma, and molecular diagnostics. San Francisco office of Point72 Asset Management

Healthcare Venture Investor

2020 - 2021

Investing in early stage companies building the future of healthcare in the US and globally

Consultant

2018 - 2020

Responsible for managing project workstreams, supervising junior team members developing detailed analyses, generating insights, and presenting findings to both internal management and clients. Expertise in the fields of healthcare and biopharma, focusing on go-to-market/sales strategy, and customer-centric transformations. • Analyzed the US healthcare industry value chain ($477B) and modeled financial growth to 2024 (5%). Defined the economic landscape of high profitability sectors (biopharma, MedTech, and digital health), identifying future disruptors and competitive threats • Created a market overview of CNS drugs ($70B, 5% CAGR), focusing on the therapies and competitive landscape of a few select diseases (depression, epilepsy, neurodegeneration, schizophrenia) • Conducted private equity due diligence for a life-sciences tools company ($200M in revenue), determining future growth of their European market • Implemented customer-success strategy for a leading biopharma company (>$20B revenue). Facilitated customer immersion sessions to understand patient needs, stood up an ongoing patient panel throughout solution design. Identified and prioritized key solutions, helping clients bring the product to market in <6 months. • Designed sales strategy transformation for a SaaS company. Worked with the sales organization of a large B2B software company to understand their field sales strategy and customer journeys to improve their sales performance and customer experience. Also helped establish a governance structure to facilitate communication across engineering and sales organizations

Graduate Student Researcher

2013 - 2018

During my PhD, I worked with two different labs to investigate the immune response to viral and bacterial infections, using traditional lab tools (“bench science”), as well as novel computational and data science (AI/ML) methods Key Scientific findings: • Discovered a human genetic signature of respiratory viral infections: using only publicly available genetic data, I found a transcriptional signature that detects viral infection prior to symptom onset (published in Immunity Cell Press) • Determined the relationship between diet, microbiome and sepsis: worked in a multi-disciplinary team that explored how diet and microbiome influence survival to sepsis (published in PNAS) • Defined the single-cell response to bacterial infection: together with a team of bioengineers, we used advanced imaging techniques to define the macrophage response to Salmonella infection (published in Cell Systems)

Consultant

2017 - 2018

Conducted projects with the Biotech Connection Bay Area group, which is a pro-bono consulting group formed by graduate students and post-doctoral fellows from Stanford, UC Berkeley and UCSF. Example projects included helping a local biotech startup evaluate the competitive landscape for a cell-based therapy for ovarian cancer, and analyzing the need for an oncology-focused expert network to service big pharma.

Oral Communication Tutor

2015 - 2018

During my time at Stanford, I coached +50 undergraduates, graduate students, and instructors on how to improve their presentation and communication skills

Women's Leadership Challenge

2016 - 2017

Graduate Voice and Influence Fellow

2016 - 2017

Consultant

2016 - 2017